Phase 2/3 Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome

NCT07538583 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
RECRUITING
Status
16
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Quoin Pharmaceuticals